A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Takeda · NCT06671483
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 3
- Target enrollment
- 1088
- US sites recruiting
- 48
- Study start
- March 3, 2025
- Record last updated
- October 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO).
The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA who have not previously been treated with biologic disease-modifying antirheumatic drugs.
The participants will be treated with either zasocitinib, active comparator, or placebo. Participants will be in the study for up to 60 weeks.
Being studied: Zasocitinib; Active Comparator; Placebo
Conditions: Psoriatic Arthritis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Age
- The participant is aged 18 years or older at the time of signing the informed consent form (ICF). In South Korea, the age requirement for adult participants is >=19 years of age.
Disease Characteristics
- The participant has a diagnosis of PsA.
- The participant must have signs and symptoms of PsA for at least 3 months prior to screening.
- The participant meets the Classification Criteria for Psoriatic Arthritis (CASPAR criteria).
- The participant has active arthritis as shown by a minimum of >=3 tender joints in TJC68 and >=3 swollen joints in SJC66 at the screening and baseline (Day 1) visits.
- The participant has at least 1 active lesion of plaque PsO >=2 cm in diameter, or any nail or nail bed changes characteristic of PsO.
Medications for PsA
- The participant has had at least one of the following:
- Inadequate response to a nonsteroidal anti-inflammatory drug (NSAID) (not applicable in the European Union [EU]/ European Economic Area [EEA]), OR
- Inadequate response to a conventional synthetic disease-modifying antirheumatic drug (csDMARD).
Exclusion Criteria
PsA and PsO
- The participant has other disease(s) that might confound the evaluations of benefit of zasocitinib therapy, including but not limited to rheumatoid arthritis, axial spondyloarthritis, systemic lupus erythematosus, Lyme disease, gout, or fibromyalgia.
- The participant has a concomitant comorbid skin condition that, in the opinion of the investigator, would interfere with the study assessments, such as evidence of non-plaque PsO (erythrodermic, pustular, predominately guttate PsO, inverse, or drug-induced PsO).
Recruiting US locations
AARR- Chandler AZ
Chandler, AZ 85225
Site contact: Site Contact · 480-443-8400 · al-khoudari.research@azarthritis.com
Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ
Phoenix, AZ 85032
Site contact: Site Contact · 480-443-8400 · chohan.research@azarthritis.com
Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ
Phoenix, AZ 85032
Site contact: Site Contact · 602-386-4972 · soloman.research@azarthritis.com
First OC Dermatology Research Inc.
Fountain Valley, CA 92708
Site contact: Site Contact · 714-531-2966 · vivian.laquer@firstocdermresearch.com
Purushotham & Akther Kotha MD
La Mesa, CA 91942
Site contact: Site Contact · 619-229-1995 · roshankotha@gmail.com
Triwest Research Associates LLC
La Mesa, CA 91942
Site contact: Site Contact · 619-334-4735 · drmabaquiao@triwestresearch.com
The Cohen Medical Centers
Thousand Oaks, CA 91360-3967
Site contact: Site Contact · 805-728-0050 · Scohen@sclamanagement.com
Foothill Arthritis Clinic
Tujunga, CA 91042
Site contact: Site Contact · 213-281-5146 · vipul@medvinresearch.com
Denver Arthritis Clinic | Denver, CO
Denver, CO 80230
Site contact: Site Contact · 303-394-2828 · rantolini@dacdenver.com
Arthritis & Rheumatic Disease Specialties (AARDS)
Aventura, FL 33180
Site contact: Site Contact · 305-652-6676 · drnbg@rheum.com
RASF- Clinical Research Center
Boca Raton, FL 33486-1390
Site contact: Site Contact · 5651-361-6547 · sbb61@aol.com
Clinical Research of West Florida | Clearwater, FL
Clearwater, FL 33765
Site contact: Site Contact · 727-466-0078 · rlevin@crwf.com
GNP Research, LLC | Hollywood, FL
Cooper City, FL 33024
Site contact: Site Contact · 754-248-3589 · mjaffe@gnpresearch.com
Tectum Medical Research
Davie, FL 33024
Site contact: Site Contact · 954-704-1050 · Lilliam.miranda@tectumresearch.com
Sweet Hope Research Specialty, Inc, d/b/a Neoclinical Research
Hialeah, FL 33016
Site contact: Site Contact · 305-456-9062 · csesin1979@aol.com
Bioresearch Partners
Miami, FL 33143
Site contact: Site Contact · 833-489-4968 · okromomd@bioresearchpartner.com
Millennium Research | Ormond Beach, FL
Ormond Beach, FL 32174
Site contact: Site Contact · 386-672-1985 · drkohen1@gmail.com
IRIS Research and Development | Plantation, FL
Plantation, FL 33324
Site contact: Site Contact · 954-476-2338 · drvalenzuela@irisrheumatology.com
Sarasota Arthritis Research Center
Sarasota, FL 34239
Site contact: Site Contact · 941-365-0770 · jboodoo@arthritiscenters.net
West Broward Rheumatology Associates, Inc.
Tamarac, FL 33321
Site contact: Site Contact · 954-724-5560 · wbral.ramrattan@gmail.com
Clinical Research of West Florida | Tampa, FL
Tampa, FL 33606
Site contact: Site Contact · 813-870-1292 · jcarter@crwf.com
Marietta Rheumatology Associates
Marietta, GA 30060
Site contact: Site Contact · 770-372-3962 · rquerubin@csi-research.com
GSCP/CIS
Orland Park, IL 60467
Site contact: Site Contact · 847-599-2492 · cconniff@cisresearch.com
Greater Chicago Specialty Physicians LLC/CIS
Schaumburg, IL 60195
Site contact: Site Contact · 847-599-2492 · kchaudhary@cisresearch.com
Accurate Clinical Research, Inc. | Lake Charles
Lake Charles, LA 70605
Site contact: Site Contact · 337-312-8617 · emendezmd@accurateclinicalresearch.com
Klein & Associates, M.D., P.A.
Hagerstown, MD 21740
Site contact: Site Contact · 301-724-4337 · mhowell@rheumdocs.com
Michigan Rheumatology Group, P.C. - Grand Blanc Office
Grand Blanc, MI 48439-2451
Site contact: Site Contact · 810-694-0082 · akarrar@aamrc.net
Ash Research Clinic - Howell
Howell, MI 48843
Site contact: Site Contact · mir.asghar@ashresearchclinic.com
June DO, PC Private Practice - Dr. Justus Fiechtner
Lansing, MI 48911-4285
Site contact: Site Contact · 517-272-9727 · joshua.june@glcor.com
Clinical Research Institute of Michigan
Saint Clair Shores, MI 48081
Site contact: Site Contact · 586-598-3329 · asulich@msn.com
Saint Louis Rheumatology
St Louis, MO 63119
Site contact: Site Contact · 314-646-0688 · cronholm@stlrheum.com
Albuquerque Center for Rheumatology PC
Albuquerque, NM 87102-1710
Site contact: Site Contact · 505-242-6190 · leroyp@abqrheum.net
Santa Fe Rheumatology
Santa Fe, NM 87505-1102
Site contact: Site Contact · 505-988-7568 · drnorton@inspiresantafe.com
NYU Langone Health | Joseph S. and Diane H. Steinberg Ambulatory Care Center - Rheumatology Department
Brooklyn, NY 11201
Site contact: Site Contact · 347-390-7798 · davidgoddardpi@gmail.com
Accellacare of Hickory
Hickory, NC 28602
Site contact: Site Contact · 828-345-5060 · rdc3s@yahoo.com
University Hospitals | UH Cleveland Medical Center - Department of Medicine - Rheumatology Division
Cleveland, OH 44106
Site contact: Site · 216-286-1246 · marina.magrey@uhhospitals.org
Paramount Medical Research & Consulting, LLC
Middleburg Heights, OH 44130
Site contact: Site Contact · 440-826-0742 · idiabmd@gmail.com
PA Regional Center for Arthritis and Osteoporosis Research
Wyomissing, PA 19610-3206
Site contact: Site Contact · 610-374-8133 · gemkeyresearch@emkeyarthritis.com
West Tennessee Research Institute
Jackson, TN 38305
Site contact: Site Contact · 731-633-0145 · aresearch@arthritisclinic.org
Accurate Clinical Research
Baytown, TX 77521
Site contact: Site Contact · 832-705-7839 · snajammd@accurateclinicalresearch.com
Novel Research | Bellaire Location
Bellaire, TX 77024
Site contact: Site Contact · 832-757-8490 · neiman@novelresearch.net
Novel Research | Bellaire Location
Bellaire, TX 77024
Site contact: Site Contact · 832-400-2262 · wajeeha@novelresearch.net
Accurate Clinical Research
Houston, TX 77089
Site contact: Site Contact · 281-240-1045 · pwallermd@accurateclinicalresearch.com
Introscience Research | Northwest Houston Arthritis Center - Houston, TX
Houston, TX 77090
Site contact: Site Contact · 832-834-5627 · adnan@novelresearch.net
West Texas Clinical Research
Lubbock, TX 79424
Site contact: Site Contact · 806-993-1040 · jitendra.vasandani@yahoo.com
Southwest Rheumatology Research, LLC | Mesquite, TX
Mesquite, TX 75150
Site contact: Site Contact · 972-288-2600 · asinghal@swrr.net
Clinical Investigations of Texas
Plano, TX 75075
Site contact: Site Contact · 972-599-1530 · Fehmida.zahabi@citplano.com
Arthritis Northwest, PLLC | Spokane, WA
Spokane, WA 99204
Site contact: Site Contact · 509-838-6500 · tcone@arthritisnw.com
Study contacts (from the official record)
- Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Similar studies in Arizona
All dermatology studies in Arizona →- RecruitingPhase 2
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Oruka Therapeutics, Inc.
- Location
- Phoenix, AZ + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Nektar Therapeutics
- Location
- Phoenix, AZ + 18 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Sanofi
- Location
- Scottsdale, AZ + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Sanofi
- Location
- Phoenix, AZ + 16 other US sites
- Eligibility basics
- Ages 18+